Xtant Medical (XTNT) Prices 20M Share Offering at $0.75/sh
Xtant Medical Holdings (NYSE:), Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced it has entered into a securities purchase agreement with accredited investors to sell shares of its common stock in a private placement. The Company agreed to issue an aggregate of 20,000,000 shares of common stock at a purchase price of $0.75 per share, resulting in gross proceeds of $15 million.
The Company expects to use the net proceeds from the private placement for working capital and other general corporate purposes. The closing of the private placement is expected to occur on or about July 6, 2023, subject to the satisfaction of customary closing conditions.
Craig-Hallum Capital Group LLC is acting as sole placement agent for the private placement.
The private placement is being made pursuant to the exemption from securities registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and Rule 506 of Regulation D as promulgated by the United States Securities and Exchange Commission (SEC), and the shares being sold in the private placement may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The Company has agreed to file a registration statement with the SEC covering the resale of the shares of common stock issued in the private placement.
This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.
